Literature DB >> 26935590

The significance of naturally occurring neuraminidase quasispecies of H5N1 avian influenza virus on resistance to oseltamivir: a point of concern.

Nalini Schaduangrat1, Jiraphorn Phanich2, Thanyada Rungrotmongkol3,4, Hatairat Lerdsamran5, Pilaipan Puthavathana5, Sukathida Ubol1.   

Abstract

Viral adaptability and survival arise due to the presence of quasispecies populations that are able to escape the immune response or produce drug-resistant variants. However, the presence of H5N1 virus with natural mutations acquired without any drug selection pressure poses a great threat. Cloacal samples collected from the 2004-2005 epidemics in Thailand from Asian open-billed storks revealed one major and several minor quasispecies populations with mutations on the oseltamivir (OTV)-binding site of the neuraminidase gene (NA) without prior exposure to a drug. Therefore, this study investigated the binding between the NA-containing novel mutations and OTV drug using molecular dynamic simulations and plaque inhibition assay. The results revealed that the mutant populations, S236F mutant, S236F/C278Y mutant, A250V/V266A/P271H/G285S mutant and C278Y mutant, had a lower binding affinity with OTV as compared with the WT virus due to rearrangement of amino acid residues and increased flexibility in the 150-loop. This result was further emphasized through the IC50 values obtained for the major population and WT virus, 104.74 nM and 18.30 nM, respectively. Taken together, these data suggest that H5N1 viruses isolated from wild birds have already acquired OTV-resistant point mutations without any exposure to a drug.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26935590      PMCID: PMC5042091          DOI: 10.1099/jgv.0.000444

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  64 in total

1.  PROPKA3: Consistent Treatment of Internal and Surface Residues in Empirical pKa Predictions.

Authors:  Mats H M Olsson; Chresten R Søndergaard; Michal Rostkowski; Jan H Jensen
Journal:  J Chem Theory Comput       Date:  2011-01-06       Impact factor: 6.006

2.  Permissive secondary mutations enable the evolution of influenza oseltamivir resistance.

Authors:  Jesse D Bloom; Lizhi Ian Gong; David Baltimore
Journal:  Science       Date:  2010-06-04       Impact factor: 47.728

Review 3.  Influenza: old and new threats.

Authors:  Peter Palese
Journal:  Nat Med       Date:  2004-12       Impact factor: 53.440

4.  Outside-binding site mutations modify the active site's shapes in neuraminidase from influenza A H1N1.

Authors:  Luis Tolentino-Lopez; Aldo Segura-Cabrera; Paola Reyes-Loyola; Mirko Zimic; Miguel Quiliano; Veronica Briz; Angeles Muñoz-Fernández; Mario Rodríguez-Pérez; Ian Ilizaliturri-Flores; Jose Correa-Basurto
Journal:  Biopolymers       Date:  2013-01       Impact factor: 2.505

5.  Molecular dynamics simulations suggest that electrostatic funnel directs binding of Tamiflu to influenza N1 neuraminidases.

Authors:  Ly Le; Eric H Lee; David J Hardy; Thanh N Truong; Klaus Schulten
Journal:  PLoS Comput Biol       Date:  2010-09-23       Impact factor: 4.475

6.  Impact of influenza A virus neuraminidase mutations on the stability, activity, and sensibility of the neuraminidase to neuraminidase inhibitors.

Authors:  Mathilde Richard; Claire Deléage; Mendy Barthélémy; Yi Pu Lin; Alan Hay; Bruno Lina; Olivier Ferraris
Journal:  J Clin Virol       Date:  2008-01       Impact factor: 3.168

7.  Understanding of known drug-target interactions in the catalytic pocket of neuraminidase subtype N1.

Authors:  Maturos Malaisree; Thanyada Rungrotmongkol; Panita Decha; Pathumwadee Intharathep; Ornjira Aruksakunwong; Supot Hannongbua
Journal:  Proteins       Date:  2008-06

8.  Zanamivir-resistant influenza viruses with a novel neuraminidase mutation.

Authors:  Aeron C Hurt; Jessica K Holien; Michael Parker; Anne Kelso; Ian G Barr
Journal:  J Virol       Date:  2009-07-29       Impact factor: 5.103

Review 9.  Mutations of neuraminidase implicated in neuraminidase inhibitors resistance.

Authors:  Olivier Ferraris; Bruno Lina
Journal:  J Clin Virol       Date:  2007-12-11       Impact factor: 3.168

Review 10.  Antiviral agents active against influenza A viruses.

Authors:  Erik De Clercq
Journal:  Nat Rev Drug Discov       Date:  2006-12       Impact factor: 84.694

View more
  4 in total

1.  Genotypic Variants of Pandemic H1N1 Influenza A Viruses Isolated from Severe Acute Respiratory Infections in Ukraine during the 2015/16 Influenza Season.

Authors:  Oksana Zolotarova; Anna Fesenko; Olga Holubka; Larysa Radchenko; Eric Bortz; Iryna Budzanivska; Alla Mironenko
Journal:  Viruses       Date:  2021-10-21       Impact factor: 5.048

Review 2.  Advancements in Host-Based Interventions for Influenza Treatment.

Authors:  Tsz-Fung Yip; Aisha Sami Mohammed Selim; Ida Lian; Suki Man-Yan Lee
Journal:  Front Immunol       Date:  2018-07-10       Impact factor: 7.561

3.  Discovery of Multitarget-Directed Ligands Against Influenza A Virus From Compound Yizhihao Through a Predictive System for Compound-Protein Interactions.

Authors:  Lvjie Xu; Wen Jiang; Hao Jia; Lishu Zheng; Jianguo Xing; Ailin Liu; Guanhua Du
Journal:  Front Cell Infect Microbiol       Date:  2020-02-11       Impact factor: 5.293

4.  Characterization of the In Vitro and In Vivo Efficacy of Baloxavir Marboxil against H5 Highly Pathogenic Avian Influenza Virus Infection.

Authors:  Keiichi Taniguchi; Yoshinori Ando; Masanori Kobayashi; Shinsuke Toba; Haruaki Nobori; Takao Sanaki; Takeshi Noshi; Makoto Kawai; Ryu Yoshida; Akihiko Sato; Takao Shishido; Akira Naito; Keita Matsuno; Masatoshi Okamatsu; Yoshihiro Sakoda; Hiroshi Kida
Journal:  Viruses       Date:  2022-01-08       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.